The Pharmaceutical industry is experiencing exciting times, coupling the continual drive for growth – through markets as well as new products – with the need for a major focus on cost containment, profitability management and improved ROI. Regardless of wherever an organization is located, a myriad of complex forces are influencing the industry:

• The perpetual search for the next major drug but coupled with an corporate desire to move away from the blockbuster paradigm, with its requisite focus on playing the odds, with high capital outlays and investments
• The relentless battle for and against generics (depending on the side of the fence a particular company sits on)
• Continuing industry consolidation, driving further competitive pressures and diversification beyond simply the ‘drug’ to a more diversified healthcare picture
• Increasing regulatory involvement not only from the traditional cost containment perspective, whether or not a particular geography has adopted a nationally funded healthcare system, but also,
• A growing focus on outcomes visibility and performance management on the part of a particular medicine, resulting in greater pressures on performance, and the related compensation or reimbursement resultant from such developments
• A changing sales and marketing model driven by a shift in the “point of influence” across the value chain, resulting in direct and strategic implications for organizations used to the ‘doctor influence’ model of brand development and growth
• A clear drive towards new emergent technologies designed to provide greater communication across all aspects of the broad industry value chain resulting (potentially) in reduced costs, improved information transparency, improved outcomes and more sustainable product and regulatory developments
• A fundamental emerging shift in go to market models away from single product views to broader health and wellness treaments

At the Smart Cube, we help our clients gain actionable insights and assess the critical impact of changes within the pharma, biopharma and life sciences space to help meet both top and bottom line goals. We work with our clients to better understand the macro and micro picture of the industry, from regulatory developments and their impacts to strategic business paradigms and their shifts. We assist our clients in meeting their operational goals through improved cost management driven by insights across both direct and indirect areas of spend, identifying emerging supply chain trends and developing a more fundamental picture of the cost elements (and their business implications) across all areas of the value chain. To learn more about our offerings in Pharmaceuticals space, please contact us.